Technology: Cancer
Industry: PharmTech
Headquarters: Geneva, Geneve, Switzerland
Founded Date: 7-4
Employees Number: 11-50
Funding Status: M&A
Investors Number: 9
Total Funding: $45.3M
Estimated Revenue: $1M to $10M
Last Funding Type: Series B

Visit Website
contact@amaltherapeutics.com
Register and Claim Ownership